The Veracyte Convergent Genomics acquisition includes $150 million of upfront cash and adds a urine-based bladder cancer testing platform.
Browsing: Markets
Ascendis TransCon rights in metabolic and cardiovascular diseases will revert from Novo Nordisk as the company authorizes a $400 million buyback.
The Rasonque Breakthrough Therapy designation covers first-line metastatic pancreatic cancer treatment in combination with standard…
The Abbott infant formula settlement resolves federal, state and relator claims connected with manufacturing and the company’s 2022 recall.
The Ultragenyx GNE myopathy treatment received FDA orphan designation, supporting development for a rare inherited muscle-wasting disorder.
Claude for Financial Advisors combines workflow skills and data connectors for research, meeting preparation and documentation tasks.
The Kennametal NASCAR partnership will provide advanced metal-cutting products and application expertise for the racing organization’s…
The Pinterest Nvidia AI layer supports visual search, content understanding and safety while sharply reducing response startup and overall latency.
The Waymo Las Vegas robotaxi service has begun fully autonomous public trips, with over 100,000 people expressing interest before launch.
The Viasat Space42 Equatys platform will receive up to $1 billion of initial founder equity to extend mobile coverage through satellite infrastructure.